Meropenem Pdr for Soln Inj/Inf 0.5g Μάλτα - Αγγλικά - Medicines Authority

meropenem pdr for soln inj/inf 0.5g

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - meropenem trihydrate - powder for solution for infusion or injection - meropenem trihydrate 500 mg - antibacterials for systemic use

Meropenem Pdr for Soln Inj/Inf 1g Μάλτα - Αγγλικά - Medicines Authority

meropenem pdr for soln inj/inf 1g

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - meropenem trihydrate - powder for solution for infusion or injection - meropenem trihydrate 1 g - antibacterials for systemic use

MEROPENEM JUNO meropenem (as trihydrate) 500 mg powder for injection vial Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

meropenem juno meropenem (as trihydrate) 500 mg powder for injection vial

juno pharmaceuticals pty ltd - meropenem trihydrate, quantity: 570 mg - injection, powder for - excipient ingredients: sodium carbonate - meropenem juno is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,,? community acquired lower respiratory tract infection ,,? hospital acquired lower respiratory tract infection,,? complicated urinary tract infection,,? febrile neutropaenia,,? intra-abdominal and gynaecological (poly microbial) infections,,? complicated skin and skin structure infections,,? meningitis,,? septicaemia

MEROPENEM JUNO meropenem (as trihydrate) 1 g powder for injection vial Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

meropenem juno meropenem (as trihydrate) 1 g powder for injection vial

juno pharmaceuticals pty ltd - meropenem trihydrate, quantity: 1140 mg - injection, powder for - excipient ingredients: sodium carbonate - meropenem juno is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,,? community acquired lower respiratory tract infection ,,? hospital acquired lower respiratory tract infection,,? complicated urinary tract infection,,? febrile neutropaenia,,? intra-abdominal and gynaecological (poly microbial) infections,,? complicated skin and skin structure infections,,? meningitis,,? septicaemia

MEROPENEM MEDIPHA SANTE 500 Milligram Pdr for Soln Inj/Inf Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

meropenem medipha sante 500 milligram pdr for soln inj/inf

medipha sante sn - meropenem trihydrate, meropenem - pdr for soln inj/inf - 500 milligram - carbapenems

MEROPENEM MEDIPHA SANTE 1 Grams Pdr for Soln Inj/Inf Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

meropenem medipha sante 1 grams pdr for soln inj/inf

medipha sante sn - meropenem trihydrate, meropenem - pdr for soln inj/inf - 1 grams - carbapenems

Meropenem-AFT Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

meropenem-aft

aft pharmaceuticals ltd - meropenem trihydrate 1140mg equivalent to meropenem 1000mg;   - powder for injection - 1000 mg - active: meropenem trihydrate 1140mg equivalent to meropenem 1000mg   excipient: sodium carbonate - meropenem-aft is indicated for treatment, in adults and children, of the following infections caused by multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: · lower respiratory tract infections · urinary tract infections, including complicated infections · intra-abdominal infections · gynaecological infections, including postpartum infections · skin and skin structure infections · meningitis · septicaemia · empiric treatment, including initial monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients because of its broad spectrum of bactericidal activity against gram positive and gram-negative aerobic and anaerobic bacteria, meropenem is effective for the treatment of polymicrobial infections.

Meropenem-AFT Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

meropenem-aft

aft pharmaceuticals ltd - meropenem trihydrate 570mg equivalent to meropenem 500mg;   - powder for injection - 500 mg - active: meropenem trihydrate 570mg equivalent to meropenem 500mg   excipient: sodium carbonate - meropenem-aft is indicated for treatment, in adults and children, of the following infections caused by multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: · lower respiratory tract infections · urinary tract infections, including complicated infections · intra-abdominal infections · gynaecological infections, including postpartum infections · skin and skin structure infections · meningitis · septicaemia · empiric treatment, including initial monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients because of its broad spectrum of bactericidal activity against gram positive and gram-negative aerobic and anaerobic bacteria, meropenem is effective for the treatment of polymicrobial infections.

Meropenem Infomed 500 mg powder for solution for injection/infusion Μάλτα - Αγγλικά - Medicines Authority

meropenem infomed 500 mg powder for solution for injection/infusion

infomed fluids srl blvd. theodor pallady 50, sector 3 032266 bucharest , romania - meropenem trihydrate - powder for solution for injection/infusion - meropenem trihydrate 500 mg - antibacterials for systemic use

Meropenem Infomed 1g powder for solution for injection/infusion Μάλτα - Αγγλικά - Medicines Authority

meropenem infomed 1g powder for solution for injection/infusion

infomed fluids srl blvd. theodor pallady 50, sector 3 032266 bucharest , romania - meropenem trihydrate - powder for solution for injection/infusion - meropenem trihydrate 1 g - antibacterials for systemic use